We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Akoya Biosciences Inc is an innovative life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery and clinical research. The company offers the most comprehensive, end-to-end solutions for high-parameter tissue analysis from discovery through clini... Akoya Biosciences Inc is an innovative life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery and clinical research. The company offers the most comprehensive, end-to-end solutions for high-parameter tissue analysis from discovery through clinical and translational research, enabling the development of more precise therapies for immuno-oncology and other drug development applications. Show more
MARLBOROUGH, Mass. and FRANKFURT, Germany, May 09, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA), The Spatial Biology Company®, and NeraCare, a leading developer of laboratory...
MARLBOROUGH, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (Nasdaq: AKYA), The Spatial Biology Company®, has opened its Operations and Manufacturing Center of Excellence in...
MARLBOROUGH, Mass. and SHANGHAI, China, May 02, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA), The Spatial Biology Company®, and Shanghai KR Pharmtech, a leading company...
MARLBOROUGH, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will release financial results for...
MARLBOROUGH, Mass., April 05, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (Nasdaq: AKYA), The Spatial Biology Company®, today announced it will highlight case studies featuring its Spatial...
Q4 2023 revenue $26.5 million and FY 2023 revenue $96.6 millionGuiding FY 2024 revenue range $114.0-118.0 million and operating cash flow breakeven by YE 2024 MARLBOROUGH, Mass., March 04, 2024...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.47 | 11.6915422886 | 4.02 | 4.58 | 3.8706 | 90465 | 4.06765114 | CS |
4 | 0.19 | 4.41860465116 | 4.3 | 4.58 | 3.72 | 122394 | 3.9423848 | CS |
12 | -1.05 | -18.9530685921 | 5.54 | 6.31 | 3.72 | 160961 | 4.73874457 | CS |
26 | 0.43 | 10.5911330049 | 4.06 | 6.31 | 3.6223 | 174909 | 4.85340255 | CS |
52 | -2.15 | -32.3795180723 | 6.64 | 8.8 | 3.04 | 189416 | 5.34074477 | CS |
156 | -15.55 | -77.5948103792 | 20.04 | 23.4426 | 3.04 | 148790 | 9.86999713 | CS |
260 | -21.51 | -82.7307692308 | 26 | 28.94 | 3.04 | 150403 | 10.30451842 | CS |
Symbol | Price | Vol. |
---|---|---|
GWAVGreenwave Technology Solutions Inc | $ 0.0717 (23.41%) | 145.88M |
SGDSafe and Green Development Corporation | $ 0.788 (27.10%) | 90.21M |
CPOPPop Culture Group Company Ltd | $ 2.9304 (72.38%) | 70.91M |
SQQQProShares UltraPro Short QQQ | $ 10.6698 (-0.65%) | 64.42M |
FFIEFaraday Future Intelligent Electric Inc | $ 0.0412 (-1.44%) | 57.52M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions